Analysis of patents on preeclampsia detection and diagnosis: A perspective

Placenta

Volumn 34, Issue 1, 2013, Pages 2-8

  Telang, M A ^a   Bhutkar, S P ^a   Hirwani, R R ^a  

^a CSIR Unit for Research and Development of Information Products   (India)

Author keywords

Diagnosis; Marker; Patent; Preeclampsia

Indexed keywords

ARTICLE; BLOOD CLOTTING; BRAIN; DIABETES MELLITUS; EARLY DIAGNOSIS; HUMAN; HYPERTENSION; KIDNEY; LIVER; MEDICAL INFORMATION; OBESITY; PATENT; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

FEMALE; HUMANS; MODELS, BIOLOGICAL; OBSTETRICS; PATENTS AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 84872045901     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2012.10.017     Document Type: Article

References (32)

1. http://www.preeclampsia.org.
2. K.A. Pennington, J.M. Schlitt, and D.L. Jackson Preeclampsia: multiple approaches for a multifactorial disease Dis Model Mech 5 1 2012 9 18
3. C. Lam, K.H. Lim, and S.A. Karumanchi Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia Hypertension 46 2005 1077 1085
4. A. Hawfield, and B.I. Freedman Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection Ther Adv Cardiovasc Dis 3 1 2009 65 73
5. L.C.Y. Poon, R. Akolekar, R. Lachmann, J. Beta, and K.H. Nicolaides Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks Ultrasound Obstet Gynecol 35 2010 662 670
6. R. Akolekar, A. Syngelaki, R. Sarquis, M. Zvanca, and K.H. Nicolaides Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks Prenat Diagn 31 2011 66 74
7. I. Cetin, B. Huppertz, G. Burton, H. Cuckle, R. Gonen, and O. Lapaire Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 32 Suppl. 2011 S4 S16
8. M.U. Baumann, N.A. Bersinger, and D.V. Surbek Serum markers for predicting pre-eclampsia Mol Aspects Med 28 2007 227 244
9. T.A. Facca, G.M. Kirsztajn, and N. Sass Preeclampsia (marker of chronic kidney disease): from genesis to future risks J Bras Nefrol 34 1 2012 87 93
10. U.D. Anderson, M.G. Olsson, K.H. Kristensen, B. Åkerström, and S.R. Hansson Review: biochemical markers to predict preeclampsia Trophoblast Res, 26 Placenta 33 Suppl. A 2012 S42 S47
11. A.F. Konski, and D.J.F. Spielthenner Stem cell patents: a landscape analysis Nat Biotechnol 27 8 2009 723
12. K.R. Sastry, H.B. Rashmi, and J. Badri Research and development perspectives of transgenic cotton: evidence from patent landscape studies J Intellect Prop Rights 16 2011 139 153
13. Report of the national high blood pressure education program working group on high blood pressure in pregnancy Am J Obstet Gynecol 183 1 2000 S1 S22
14. B. Huppertz Placental origins of preeclampsia: challenging the current hypothesis Hypertension 51 4 2008 970 975
15. E.A.P. Steegers, P.V. Dadelszen, J.J. Duvekot, and R. Pijnenborg Pre-eclampsia Lancet 376 2010 631 644
16. E.J. Wortelboer, M.P. Koster, H.S. Cuckle, P.H. Stoutenbeek, P.C. Schielen, and G.H. Visser First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia BJOG 117 11 2010 1384 1389
17. Francois Audibert Maternal serum screening for preeclampsia: is performance enough? Clin Biochem 43 9 2010 707 708
18. A.O. Odibo, Y. Zhong, K.R. Goetzinger, L. Odibo, J.L. Bick, and C.R. Bower First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia Placenta 32 2011 598 602
19. C.L. Haggerty, M.E. Seifert, G. Tang, J. Olsen, D.C. Bass, and S.A. Karumanchi Second trimester anti-angiogenic proteins and preeclampsia Pregnancy Hypertens 2 2 2012 158 163
20. H. Hagmann, R. Thadhani, T. Benzing, S.A. Karumanchi, and H. Stepan The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia Clin Chem 58 5 2012 837 845
21. S. Rana, C.E. Powe, S. Salahuddin, S. Verlohren, F.H. Perschel, and R.J. Levine Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia Circulation 125 7 2012 911 919
22. S.B. Lee, A.P. Wong, K. Kanasaki, Y. Xu, V.K. Shenoy, and T.F. McElrath Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions Am J Pathol 176 2 2010 710 720
23. K. Palmer, B. Saglam, C. Whitehead, O. Stock, M. Lappas, and S. Tong Severe early-onset preeclampsia is not associated with a change in placental catechol O-methyltransferase (COMT) expression Am J Pathol 178 6 2011 2484 2488
24. L.T. Roten, M.H. Fenstad, S. Forsmo, M.P. Johnson, E.K. Moses, and R. Austgulen A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2) Mol Hum Reprod 17 7 2011 439 446
25. I. Caniggia, J. Winter, S.J. Lye, and M. Post Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia Placenta 21 Suppl. A 2000 S25 S30
26. I. Caniggia, G.S. Grisaru, M. Kuliszewsky, M. Post, and S.J. Lye Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies J Clin Invest 103 12 1999 1641 1650
27. S. Gack, A. Marmé, F. Marmé, G. Wrobel, B. Vonderstrass, and G. Bastert Preeclampsia: increased expression of soluble ADAM 12 J Mol Med (Berl) 83 11 2005 887 896
28. H. Nishizawa, K. Pryor-Koishi, M. Suzuki, T. Kato, H. Kogo, and T. Sekiya Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients Mol Hum Reprod 14 10 2008 595 602
29. D.B. Brubaker, M.G. Ross, and D. Marinoff The function of elevated plasma fibronectin in preeclampsia Am J Obstet Gynecol 166 2 1992 Feb 526 531
30. S. Muttukrishna, R.A. North, J. Morris, J.C. Schellenberg, R.S. Taylor, and J. Asselin Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia Hum Reprod 15 7 2000 1640 1645
31. H. Mise, N. Sagawa, T. Matsumoto, S. Yura, H. Nanno, and H. Itoh Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia J Clin Endocrinol Metab 83 9 1998 3225 3229
32. D.W. Virginia, G. Matthew, C.P. Agnes, K.S. Kasper, K. Anita, and K.R. Kristen Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2 Endocrinology 150 1 2009 452 462